CareMax, Inc. Schedules Second Quarter 2022 Earnings Conference Call

Rhea-AI Summary

CareMax, Inc. (NASDAQ: CMAX; CMAXW) will announce its Q2 2022 financial results on August 9, 2022, before market opening. A conference call at 8:30 am ET will follow to discuss these results. The call can be accessed at (888) 440-6519 for U.S. participants or (646) 960-0384 for international ones, using conference ID 4345921. A live webcast and replay will be available on its investor relations website.

Positive

• Upcoming financial results announcement for Q2 2022 could provide clarity on performance.
• Scheduled conference call indicates transparency and engagement with investors.

Negative

• None.

MIAMI--(BUSINESS WIRE)-- CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced that it will release its financial results for the second quarter 2022 before the opening of the financial markets on Tuesday, August 9, 2022, and host a conference call at 8:30 am Eastern Time the same day to discuss the results.

The conference call can be accessed by dialing (888) 440-6519 for U.S. participants, or (646) 960-0384 for international participants, and referencing conference ID 4345921. A live audio webcast and replay of the event will also be available on the “Events & Presentations” section of CareMax’s investor relations website at ir.caremax.com.

About CareMax

CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors. CareMax operates medical centers that offer a comprehensive suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States. Learn more at www.caremax.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth and strategy. Words such as "anticipate," "believe," "budget," "contemplate," "continue," "could," "envision," "estimate," "expect," "guidance," "indicate," "intend," "may," "might," "plan," "possibly," "potential," "predict," "probably," "pro-forma," "project," "seek," "should," "target," or "will," or the negative or other variations thereof, and similar words or phrases or comparable terminology, are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important risks and uncertainties that could cause the Company's actual results and financial condition to differ materially from those indicated in forward-looking statements include, among others, the availability of sites for medical facilities and the costs of opening such medical facilities; changes in market or industry conditions, regulatory environment, competitive conditions, and receptivity to the Company's services; the Company's ability to continue its growth, including in new markets; changes in laws and regulations applicable to the Company's business, in particular with respect to Medicare Advantage or Medicaid; the Company's ability to maintain its relationships with health plans and other key payers; the impact of COVID-19 or another pandemic, epidemic or outbreak of infectious disease on the Company's business and results of operation; and the Company's ability to recruit and retain qualified team members and independent physicians. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in the Company's reports filed with the SEC. All information provided in this press release is as of the date hereof, and the Company undertakes no duty to update or revise this information unless required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220720005167/en/

Investor Relations

Samantha Swerdlin

VP Investor Relations

(847) 924-8980

samantha.swerdlin@caremax.com

Media

Christine Bucan

(305) 542-8855

christine@thinkbsg.com

Source: CareMax, Inc.

FAQ

When will CareMax announce its Q2 2022 financial results?

CareMax will announce its Q2 2022 financial results on August 9, 2022.

What time is the conference call for CareMax's Q2 results?

The conference call will be held at 8:30 am Eastern Time on August 9, 2022.

How can I access the CareMax conference call?

The conference call can be accessed by calling (888) 440-6519 for U.S. participants or (646) 960-0384 for international participants, using conference ID 4345921.